Abstract
Background: Patients of Pulmonary Tuberculosis continued to be suffering from the adverse effects of the Anti-tubercular drugs even though they are used efficiently, the rate of infection of pulmonary tuberculosis is not satisfactory under control. Hence the present study was conducted, to study the efficacy and to minimize the side effects of present therapy (DOTs) by using along with Ayurveda formulation. Objectives: To Study the efficacy of Jivantyadi Ghrit as Add-on treatment in PTB treating with AKT (DOTs) regimen. Materials and Methods: It was an open labelled, controlled clinical study. It was conducted in 28 patients of PTB for six months. Results: There was significant reduction in group B patients regarding cough with expectoration, loss of appetite, loss of weight, evening rise of temperature, burning feet and hands. Significant reduction in side effects. There was significant reduction of score in lymphocyte count in group B patients. Conclusion: Study shows the scientific good evidences of add-on therapy of Jivantyadi Ghrit with AKT (DOTs) in the management of PTB.
Highlights
Tuberculosis is caused by Mycobacterium tuberculosis which is communicable, chronic granulomatous disease.[Kasper et al (n.d.)] It usually involves the lungs, the pulmonary tuberculosis because of the high content of the lipase
Since that time human being suffering from the disease. It is the disease of pranavaha strotas
The study was an active, controlled, randomized study, designed to evaluate the efficacy of Jivantyadi Ghrut as add- on treatment in PTB treating with AKT (DOTs) regimen after 180 days of treatment
Summary
Patients of Pulmonary Tuberculosis continued to be suffering from the adverse effects of the Anti-tubercular drugs even though they are used efficiently, the rate of infection of pulmonary tuberculosis is not satisfactory under control. The present study was conducted, to study the efficacy and to minimize the side effects of present therapy (DOTs) by using along with Ayurveda formulation. Objectives: To Study the efficacy of Jivantyadi Ghrit as Add-on treatment in PTB treating with AKT (DOTs) regimen. Materials and Methods: It was an open labelled, controlled clinical study. It was conducted in 28 patients of PTB for six months. Results: There was significant reduction in group B patients regarding cough with expectoration, loss of appetite, loss of weight, evening rise of temperature, burning feet and hands. There was significant reduction of score in lymphocyte count in group B patients. Conclusion: Study shows the scientific good evidences of add-on therapy of Jivantyadi Ghrit with AKT (DOTs) in the management of PTB. All decisions on design; data collection,analysis, and interpretation; and publication were completely independent of the funding source
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Ayurvedic Herbal and Integrative Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
